Ajay Sinha's Blog – December 2021 Archive (11)

Emcure Pharmaceuticals Limited

Emcure is a pharmaceutical firm that manufactures and markets tablets, capsules and injectables.

Emcure is headquartered in Pune, Maharashtra. Satish Mehta is the Founder & CEO of Emcure. Emcure has acquired 3 companies, with the most recent being Marcan Pharmaceuticals, Inc. for an undisclosed amount on Jan 2016. Emcure has 717 followers on Owler.
Read more at https://www.owler.com/company/emcure

Added by Ajay Sinha on December 6, 2021 at 4:28am — No Comments

Emcure Pharmaceuticals Limited

Emcure Pharmaceuticals Limited – Manufacturer of nucron statins tablet, nucron antiarrtyhmic tablet & nucron direct thrombin ingibitor tablet in Mumbai, Maharashtra.

Manufacturer of Nucron Statins Tablet, Nucron Antiarrtyhmic Tablet & Nucron Direct Thrombin Ingibitor Tablet offered by Emcure Pharmaceuticals Limited from Mumbai, Maharashtra, India

Read more at…

Continue

Added by Ajay Sinha on December 6, 2021 at 4:22am — No Comments

EMCURE PHARMACEUTICALS LIMITED

Emcure Pharmaceuticals Limited is an unlisted public company incorporated on 16 April, 1981. It is classified as a public limited company and is located in Pune, Maharashtra. It's authorized share capital is INR 250.00 cr and the total paid-up capital is INR 180.85 cr.

Emcure Pharmaceuticals Limited's operating revenues range is Over INR 500 cr for the financial year ending on 31 March, 2021. It's EBITDA has increased by 75.57 % over the previous year. At the same time, it's book…

Continue

Added by Ajay Sinha on December 6, 2021 at 4:19am — No Comments

The Pharma IPO Boom Continues. Which Ones Will Stand Out?

The Covid-19 pandemic created a sea of opportunities for the healthcare sector. Several pharma and specialty chemical companies launched their initial public offerings (IPOs), hastened by the disruptions brought about by the pandemic. The frenzy of IPOs shows no sign of slowing down. At least not immediately.

On Friday itself, two such firms in the space- Vijaya Diagnostic Centre and Ami Organics- are set to close their listings. Bain Capital-backed Emcure Pharmaceuticals, whose unit…

Continue

Added by Ajay Sinha on December 6, 2021 at 4:14am — No Comments

MGF vs Emaar case: Court asks for probe into Rs 180-crore transaction

Delhi court has dismissed a revision petition filed by MGF Development Ltd against the order of a Chief Metropolitan Magistrate (CMM) court involving Emaar India and MGF chairman Shravan Gupta.

The CMM court had directed to file a First Information Report (FIR) against MGF and other accused. While dismissing the petition, ASJ Dharmender Rana said that Rs 180 crore seemed to have exchanged hands without any apparent quid pro quo for the said transaction, and that the spectre of money…

Continue

Added by Ajay Sinha on December 3, 2021 at 4:53am — No Comments

EMCURE PHARMACEUTICALS LIMITED

Emcure Pharmaceuticals Limited is an unlisted public company incorporated on 16 April, 1981. It is classified as a public limited company and is located in Pune, Maharashtra. It's authorized share capital is INR 250.00 cr and the total paid-up capital is INR 180.85 cr.

Emcure Pharmaceuticals Limited's operating revenues range is Over INR 500 cr for the financial year ending on 31 March, 2021. It's EBITDA has increased by 75.57 % over the previous year. At the same time, it's book…

Continue

Added by Ajay Sinha on December 3, 2021 at 4:45am — No Comments

The Pharma IPO Boom Continues. Which Ones Will Stand Out?

The Covid-19 pandemic created a sea of opportunities for the healthcare sector. Several pharma and specialty chemical companies launched their initial public offerings (IPOs), hastened by the disruptions brought about by the pandemic. The frenzy of IPOs shows no sign of slowing down. At least not immediately.

On Friday itself, two such firms in the space- Vijaya Diagnostic Centre and Ami Organics- are set to close their listings. Bain Capital-backed Emcure Pharmaceuticals, whose unit…

Continue

Added by Ajay Sinha on December 3, 2021 at 4:42am — No Comments

Emcure Pharmaceuticals Ltd.

Our Company was incorporated as Emcure Pharmaceuticals Private Limited on April 16, 1981 as a private limited company under the Companies Act, 1956. We are a fast growing Indian pharmaceutical company engaged in developing, manufacturing and marketing a broad range of pharmaceutical products globally. Our core strength lies in developing and manufacturing differentiated pharmaceutical products in-house, which we commercialize through our marketing infrastructure across geographies and…

Continue

Added by Ajay Sinha on December 3, 2021 at 4:40am — No Comments

Aim To Take Emcure Among Top 5 Pharma Cos: MD

Emcure Pharmaceuticals is aiming to be among the top five drug firms in the country in the next five to seven years as it also eyes acquisitions for growth going forward, a top company official said. The company is currently developing mRNA vaccine for COVID-19 through its subsidiary, Gennova Biopharmaceuticals.

"We are now currently in the top 10 pharma companies in India and I would like to take the company to the top 5 in the next five to seven years for sure. That is one thing…

Continue

Added by Ajay Sinha on December 3, 2021 at 4:37am — No Comments

Emcure Pharmaceuticals Limited

Founded in 1981 and headquartered in Pune, India, Emcure Pharmaceuticals Limited operates as a pharmaceutical company. The Company manufactures tablets, soft-ge... Read More

Headquarters

Headquarters:

Pharmaceuticals Limited Survey No 255/2, Phase I, MIDC, Rajiv Gandhi IT Park, Hinjwadi, Marunji, Maharashtra, 411057, India

Phone

Phone:

+91 20 3982 1000

Website

Website:

www.emcure.com

Employees…

Continue

Added by Ajay Sinha on December 3, 2021 at 4:31am — No Comments

Emcure Says It Will Continue Growth Momentum In FY22 By Deepening Product Portfolio, Digital Focus

Emcure Pharmaceuticals, one of the fastest-growing drug makers by sales in the domestic market, is planning to strengthen its product portfolio with new launches, line extensions of existing brands and focus on digital sales.

The privately held Pune-based company aims to bring first to market specialty or differentiated generic drugs through the company’s own R&D efforts and innovative molecules through in-licensing partnerships.…

Continue

Added by Ajay Sinha on December 3, 2021 at 4:25am — No Comments

© 2024   Created by PH the vintage.   Powered by

Badges  |  Report an Issue  |  Terms of Service